9147 Bevacizumab and erlotinib as first-line therapy in advanced (stage IIIB/IV) non-squamous non-small-cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression – a multicenter phase II trial of SAKK
Saved in:
Published in | European journal of cancer supplements Vol. 7; no. 2; p. 549 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 1359-6349 1878-1217 |
---|---|
DOI: | 10.1016/S1359-6349(09)71860-9 |